Abbott Laboratories <ABT.N) said on Monday it is interested in bolstering its line of medical devices, but it was becoming increasingly difficult to find appropriate and affordable products. Chief Executive Officer Miles White, in a conference call with industry analysts, said Abbott is interested in acquiring new medical optics and other products.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Shares of ABT traded higher by 0.87% or $0.36/share to $41.66. In the past year, the shares have traded as low as $32.70 and as high as $41.96. On average, 5561950 shares of ABT exchange hands on a given day and today's volume is recorded at 2280295.
Source
